Optibrium, Imperial College and DNDi to collaborate on drug development
The collaboration will provide MSc students with industry-relevant learning tools and pharma with a new pipeline of candidate compounds.
List view / Grid view
The collaboration will provide MSc students with industry-relevant learning tools and pharma with a new pipeline of candidate compounds.
Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design.
Researchers develop bacteria-fighting wound dressing made with the help of crustaceans…
The monoclonal antibody biopharmaceutical group Kymab announced today that it has received a $9m grant from the Bill & Melinda Gates Foundation to accelerate the development of novel vaccines and therapeutics for infectious diseases, including HIV.
10 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The technology could enable patients with HIV to be managed more effectively in remote locations and can produce a result in under 30 minutes...
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
A new biologic medication - the first for HIV - is showing promise in treating patients with multidrug resistance, according to phase 3 research...
30 September 2016 | By Niamh Louise Marriott, Digital Content Producer
A simple set of alterations to a mouse’s living space, adding toys, caused dramatic changes to their T cells, making them a more protective inflammatory...
11 August 2016 | By Medical Research Council (MRC) Laboratory of Molecular Biology
HIV is surrounded by a protein shell called the capsid. It has now been found that HIV hides within the capsid while it builds DNA...
20 July 2016 | By Niamh Louise Marriott, Digital Content Producer
The NIH recently awarded $30 million to advance science towards a cure for HIV. Drug Target Review caught up with the Wistar Institute‘s Dr. Luis Montaner, co-leader of the BEAT-HIV project...
14 July 2016 | By Victoria White, Digital Content Producer
The US National Institutes of Health has awarded $30 million in annual funding to help advance science towards a cure for HIV...
29 June 2016 | By Victoria White, Digital Content Producer
A study suggests efavirenz might be an effective therapy for stimulating cholesterol turnover from the brain and slowing or preventing Alzheimer's disease...
29 June 2016 | By Victoria White, Digital Content Producer
Scientists have described a strategy to stabilise an important HIV structure and potentially create HIV lookalikes for large-scale vaccine production...
11 April 2016 | By Victoria White, Digital Content Producer
Mymetics’ HIV vaccine candidate generated significant protection in groups of twelve female monkeys against repeated AIDS virus exposures...
6 April 2016 | By Victoria White
Scientists have described the first-ever immature antibody found in a powerful class of immune molecules effective against HIV. TSRI biologist Jiang Zhu called the antibody a “teenager” and said it gives scientists a unique view of the steps needed to prompt the immune system to effectively target HIV...
3 March 2016 | By Victoria White
According to the research, a drug for a disease that affects twice as many people will generate twice the revenue. But vaccine revenue depends on finer details about how the risk is distributed in the population...